Global Mrna Therapeutics Contract Development & Manufacturing Market Size & Outlook
Global mrna therapeutics contract development & manufacturing market, 2021-2033 (US$M)
Related Markets
Global mrna therapeutics contract development & manufacturing market highlights
- The global mrna therapeutics contract development & manufacturing market generated a revenue of USD 4,399.7 million in 2024 and is expected to reach USD 14,746.0 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 15.2% by 2033.
- In terms of segment, infectious diseases accounted for a revenue of USD 2,994.5 million in 2024.
- Metabolic & Genetic Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 4,399.7 million |
| Market revenue in 2033 | USD 14,746.0 million |
| Growth rate | 15.2% (CAGR from 2025 to 2033) |
| Largest segment | Infectious diseases |
| Fastest growing segment | Metabolic & Genetic Diseases |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases, Infectious Diseases |
Other key industry trends
- In terms of revenue, the North America accounted for 38.6% of the global mrna therapeutics contract development & manufacturing market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, UAE is the fastest growing regional market and is projected to reach USD 100.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MRNA Therapeutics Contract Development & Manufacturing Market Scope
MRNA Therapeutics Contract Development & Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BioCina | View profile | 101-250 | Thebarton, South Australia, Australia, Oceania | https://www.biocina.com/ |
| eTheRNA immunotherapies | View profile | 51-100 | Jette, Brussels Hoofdstedelijk Gewest, Belgium, Europe | http://www.etherna.be/ |
| Indication | View profile | 1-10 | Sandhausen, Baden-Wurttemberg, Germany, Europe | http://www.indication.com |
| Biomay AG | View profile | - | Vienna, Wien, Austria, Europe | https://www.biomay.com/ |
| BioNTech SE ADR | View profile | 6133 | An der Goldgrube 12, Mainz, RP, Germany, D-55131 | https://www.biontech.de |
| Kaneka Corp | View profile | 13284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | http://www.kaneka.co.jp |
| TriLink BioTechnologies | View profile | 251-500 | San Diego, California, United States, North America | http://www.trilinkbiotech.com/ |
| EQT Corp | View profile | 881 | 625 Liberty Avenue, Suite 1700, Pittsburgh, PA, United States, 15222 | https://www.eqt.com |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Apex Biotechnology | View profile | - | Hsinchu, T'ai-wan, Taiwan, Asia | http://www.apexbio.com |
| Nunn’s Home Medical Equipment | View profile | 101-250 | Rome, New York, United States, North America | https://www.nunnshme.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Samsung Electronics Co Ltd | View profile | 124804 | 129, Samsung-ro, Yeongtong-gu, Gyeonggi-do, Suwon-si, Korea, Republic of, 443-742 | https://www.samsung.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global mrna therapeutics contract development & manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 68.06% in 2024. Horizon Databook has segmented the Global mrna therapeutics contract development & manufacturing market based on metabolic & genetic diseases, cardiovascular & cerebrovascular diseases, infectious diseases covering the revenue growth of each sub-segment from 2021 to 2033.
- Global MRNA Therapeutics Contract Development & Manufacturing Indication Outlook (Revenue, USD Million, 2021-2033)
- Metabolic & Genetic Diseases
- Cardiovascular & Cerebrovascular Diseases
- Infectious Diseases
- Global MRNA Therapeutics Contract Development & Manufacturing Application Outlook (Revenue, USD Million, 2021-2033)
- Protein Replacement Therapies
- Cancer Immunotherapies
- Viral Vaccines
- Global MRNA Therapeutics Contract Development & Manufacturing End Use Outlook (Revenue, USD Million, 2021-2033)
- Biotech Companies
- Government & Academic Research Institutes
- Pharmaceutical Companies
Reasons to subscribe to Global mrna therapeutics contract development & manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global mrna therapeutics contract development & manufacturing market databook
-
Our clientele includes a mix of mrna therapeutics contract development & manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This global databook contains high-level insights into Global mrna therapeutics contract development & manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global mrna therapeutics contract development & manufacturing market size, by regions, 2021-2033 (US$M)
Top 10 countries: Mrna therapeutics contract development & manufacturing market size, 2024 (US$M)
Global mrna therapeutics contract development & manufacturing market share, by end use, 2024 & 2033 (%, US$M)
Mrna therapeutics contract development & manufacturing market: Opportunity assessment by country
Global mrna therapeutics contract development & manufacturing market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
